Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DAOIB + AO
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
DAOIB + AO is an investigational oral combination therapy comprising DAOIB, a putative NMDA receptor-enhancing agent, and an unspecified antioxidant agent (AO). This combination is being studied for the treatment of early dementia, including Alzheimer's disease and mild cognitive impairment. The rationale for this approach is based on evidence that NMDA receptor modulation can improve cognitive function in early-phase dementia and that antioxidants may provide neuroprotective effects by reducing oxidative stress. The combination aims to augment cognitive benefits beyond those achieved with NMDA enhancement alone[1][2]. The specific identity of "DAOIB" has not been disclosed in public sources as of June 2025; it is under clinical investigation.
- Other names
- DAOIB plus AODAOIB plus Antioxidant agent
02
Targets
NMDAR (Glutamate receptor ionotropic, NMDA)
Beyond the preview
Go deeper on DAOIB + AO.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DAOIB + AO.